发明名称 MODULATION OF INTRACELLULAR SIGNALING
摘要 <p>A method of treating a disease characterized by aberrant cell migration and/or invasion includes administering to a subject an effective amount of the peptide of SEQ ID NO:3, anÅ6 polypeptide, or an isolated polypeptide consisting essentially of the Link region of human CD44 as indicated in FIG. 17 to modulate a FAK signal transduction pathway for a sufficient period of time to treat the disease. A method of diagnosing a condition characterized by aberrant cell migration and/or invasion includes measuring the effect of these polypeptides on FAK signal transduction activity; wherein a change in FAK signal transduction activity is indicative of said aberrant cell migration or invasion. A method of diagnosing a condition characterized by aberrant cell migration and/or invasion includes imaging FAK signal transduction activity in the presence of these polypeptides.</p>
申请公布号 EP2542253(A1) 申请公布日期 2013.01.09
申请号 EP20110751401 申请日期 2011.03.04
申请人 ANGSTROM PHARMACEUTICALS, INC. 发明人 FINLAYSON, MALCOLM;DAMAJ, BASSAM, B.
分类号 A61K38/00;G01N33/48 主分类号 A61K38/00
代理机构 代理人
主权项
地址